摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

金刚大碱 | 71239-66-2

中文名称
金刚大碱
中文别名
喹喔啉,1,2,3,4-四氢-6-(甲硫基)-
英文名称
(+)-croomine
英文别名
croomine;(2S)-4c-methyl-3'c'-((2S)-4c-methyl-5-oxo-tetrahydro-furan-2r-yl)-(2rC8',9'r'O,9'ac')-decahydro-spiro[furan-2,9'-pyrrolo[1,2-a]azepin]-5-one;(3S,3'R,9S,9aS)-3'-methyl-3-[(2S,4S)-4-methyl-5-oxooxolan-2-yl]spiro[1,2,3,5,6,7,8,9a-octahydropyrrolo[1,2-a]azepine-9,5'-oxolane]-2'-one
金刚大碱化学式
CAS
71239-66-2
化学式
C18H27NO4
mdl
——
分子量
321.417
InChiKey
FOGTVYCUHQOMDW-QANXDEHQSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    23
  • 可旋转键数:
    1
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.89
  • 拓扑面积:
    55.8
  • 氢给体数:
    0
  • 氢受体数:
    5

SDS

SDS:b054b15e53e73dec977c634f96f2e76c
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    A new alkaloid, croomine, from Croomia heterosepala Okuyama.
    摘要:
    从石蒜科植物 Croomia heterosepala OKUYAMA 的根和根茎中分离出了一种新的主要生物碱--石蒜碱(I)。通过化学和光谱证据以及 X 射线分析确定了其结构。
    DOI:
    10.1248/cpb.27.1495
  • 作为产物:
    描述:
    3-甲基-2(5H)-呋喃酮 在 palladium on activated charcoal 盐酸氢气三乙胺三氯氧磷 作用下, 以 乙醇 为溶剂, 25.0 ℃ 、101.33 kPa 条件下, 反应 14.25h, 生成 金刚大碱
    参考文献:
    名称:
    Vinylogous Mannich 反应的应用。(+)-Croomine 的简明对映特异性全合成
    摘要:
    因为取代呋喃与亚胺离子的乙烯基曼尼希反应在生物碱合成中是一种有用的结构,所以重要的是要知道两个反应伙伴上的取代基对反应的立体选择性有什么影响。为此,研究了将甲基化呋喃 9a-h 添加到由乙氧基氨基甲酸酯 10 原位生成的亚胺离子中。通常,苏式和赤式加合物 11a-h 和 12a-h 的混合物 (3-24:1) 的总产率为 50-96%,其中苏式异构体是主要产物。使用一种新颖的策略完成了 (+)-克罗碱 (1) 的两个非常简洁的不对称合成,其中两个带有乙烯基的曼尼希反应作为关键结构突出显示。
    DOI:
    10.1021/ja990077r
点击查看最新优质反应信息

文献信息

  • Studies of Stemona alkaloids. Total synthesis of (+)-croomine
    作者:David R. Williams、David L. Brown、John W. Benbow
    DOI:10.1021/ja00187a081
    日期:1989.3
  • Vinylogous Mannich Reactions. The Asymmetric Total Synthesis of (+)-Croomine
    作者:Stephen F. Martin、Kenneth J. Barr
    DOI:10.1021/ja9542146
    日期:1996.1.1
  • Method of making antitussive medicine and relieving cough
    申请人:But Paul Pui-Hay
    公开号:US20070060564A1
    公开(公告)日:2007-03-15
    Method for relieving cough using an effective antitussive chemical compound belonging to stemoamide or tuberostemospironine and method for manufacturing pharmaceutical compositions for treating or relieving cough in human and animal subjects which including a stemoamide or tuberostemospironine compound. In addition, the antitussive property of the compounds provides a method for assessing the quality of herbs traditionally used in treating cough by analyzing the content of the effective chemical ingredient, i.e., compounds of stemoamide type and/or tuterostemospironine type. It further provides a method for identifying medicinal herbs which may be used for relieving cough by phytochemical determination of the existence of compounds that are of stemoamide or tuterostemospironine type.
  • US7867998B2
    申请人:——
    公开号:US7867998B2
    公开(公告)日:2011-01-11
  • Applications of Vinylogous Mannich Reactions. Concise Enantiospecific Total Syntheses of (+)-Croomine
    作者:Stephen F. Martin、Kenneth J. Barr、Dudley W. Smith、Scott K. Bur
    DOI:10.1021/ja990077r
    日期:1999.8.1
    extraordinarily concise asymmetric syntheses of (+)-croomine (1) have been completed using a novel strategy, highlighted by two vinylogous Mannich reactions as key constructions. The first such reaction involved the addition of 5-(4-bromobut-1-yl)-3-methyl-2-(triisopropylsilyloxy)furan to the N-acyliminium salt derived from the l-pyroglutamic acid derivative 17 to give the adduct [5(S),2‘(S),5‘(S)]-5-(4‘ 
    因为取代呋喃与亚胺离子的乙烯基曼尼希反应在生物碱合成中是一种有用的结构,所以重要的是要知道两个反应伙伴上的取代基对反应的立体选择性有什么影响。为此,研究了将甲基化呋喃 9a-h 添加到由乙氧基氨基甲酸酯 10 原位生成的亚胺离子中。通常,苏式和赤式加合物 11a-h 和 12a-h 的混合物 (3-24:1) 的总产率为 50-96%,其中苏式异构体是主要产物。使用一种新颖的策略完成了 (+)-克罗碱 (1) 的两个非常简洁的不对称合成,其中两个带有乙烯基的曼尼希反应作为关键结构突出显示。
查看更多

同类化合物

金刚大碱 百部碱 新对叶百部碱 对叶百部碱 (7aR,8R,8aS,11S,11aS,11bR,11cR)-8-乙基十二氢-11-甲基-呋喃并[2,3-h]吡咯并[3,2,1-jk][1]苯并氮杂卓-10(2H)-酮 <3'S-<3'α,9'α(S*),9'aα>>-1',2',3',5',6',7',8'-octahydro-4-methyl-5-oxospiropyrrolo<1,2-a>azepin>-3'-carboxylic acid, hydrobromide salt <3'S-<3'α(S*),9'α(S*),9'aα>>-3'-(2,5-dihydro-4-methyl-5-oxo-2-furanyl)-1',2',3',5',6',7',8'-octahydro-4-methylspiropyrrolo<1,2-a>azepin>-5-one stemoamide (2S,4R,3'S,8'R,9a'S,2’’S,4’’S)-8'-methoxy-4-methyl-3’-(4-methyl-5-oxotetrahydrofuran-2-yl)octahydro-3H-spiro{furan-2,9'-pyrrolo[1,2-a]azepine}-5(4H)-one tuberostemospiroline 2-oxostenine (3aR,10aR,10bR)-octahydro-2H-furo[3,2-c]pyrrolo[1,2-a]azepine-2,8(1H)-dione (3aR,9aS,9bR)-3a,6,8,9,9a,9b-Hexahydro-1H-3-oxa-6a-aza-cyclopenta[e]azulene-2,7-dione (2S,3'S,8'R,9a'S)-3'-tert-butyldiphenylsilyloxymethyl-8'-methoxy-1',2',3',7',8',9a'-hexahydro-5H-spiro{furan-2,9'-pyrrolo[1,2-a]azepine}-5,5'(6'H)-dione diethyl (2S,3'S,8'R,9a'S)-3'-tert-butyldiphenylsilyloxymethyl-8'-methoxy-5,5'-dioxo-1',2',3',5',6',7,'8',9a'-octahydro-5H-spiro{furan-2,9'-pyrrolo[1,2-a]azepin-4-yl}phosphonate (2S,4R,3'S,8'R,9a'S,2’’S)-8'-methoxy-4-methyl-3’-(4-methylene-5-oxotetrahydrofuran-2-yl)hexahydro-3H-spiro{furan-2,9'-pyrrolo[1,2-a]azepine}-5,5'(4H,6'H)-dione (2S,4R,3'S,8'R,9a'S,2’’R)-8'-methoxy-4-methyl-3’-(4-methylene-5-oxotetrahydrofuran-2-yl)hexahydro-3H-spiro{furan-2,9'-pyrrolo[1,2-a]azepine}-5,5'(4H,6'H)-dione (1R,2S,10R,12R,16R)-14,14-dimethyl-11,13,15-trioxa-6-azatetracyclo[8.6.0.02,6.012,16]hexadec-8-en-5-one 13-desmethyl-5-oxostenine (3aR,10aS)-1-methyl-3a,4,5,6,10,10a-hexahydro-2H-furo[3,2-c]pyrrolo[1,2-a]azepine-2,8(9H)-dione (1R,9R,10R,11S,14S,15S,16R)-14-methyl-10-prop-2-enyl-12-oxa-4-azatetracyclo[7.6.1.04,16.011,15]hexadecane-5,13-dione 8-des-ethyl-(8S)-allyl-(-)-tuberostemonine didehydrotuberostemonine (-)-4-thiostenine (-)-4-oxostenine (3aR,10aS,10bS)-octahydro-2H-furo[3,2-c]pyrrolo[1,2-a]azepine-2,8(1H)-dione (+)-9a-epi-stemoamide (2S,4R,3'S,8'R,9a'S)-3'-hydroxymethyl-8'-methoxy-4-methylhexahydro-3H-spiro{furan-2,9'-pyrrolo[1,2-a]azepine}-5,5'(4H,6'H)-dione isoprotostemonine (1S,2S,3R,4R,6R)-3-hydroxy-4-methoxy-5-oxa-10-azatricyclo[8.3.0.02,6]tridecan-11-one (1S,3aR,7S,9aS,9bR)-1-methyl-7-((2S,4S)-4-methyl-5-oxotetrahydrofuran-2-yl)decahydro-3-oxa-6a-azacyclopenta[e]azulen-2-one 4-methoxy-3-methyl-5-[(2Z,3aR)-1t-methyl-8t-((2S)-4c-methyl-5-oxo-tetrahydrofuran-2r-yl)-(3ar,10at,10bt)-decahydro-2H-furo[3,2-c]pyrrolo[1,2-a]azepin-2-ylidene]-5H-furan-2-one 8-epi-stemoamide sessilifoliamide A (2R,3'S,8'R,9a'S)-3'-(tert-butyldiphenylsilyloxy)methyl-8'-methoxy-4-methylenehexahydro-3H-spiro{furan-2,9'-pyrrolo[1,2-a]azepin}-5,5'(4H,6'H)-dione (2R,3'S,8'R,9a'S)-8'-methoxy-4-methylene-3'-[(2S)-4-methylene-5-oxotetrahydrofuran-2-yl]hexahydro-3H-spiro{furan-2,9'-pyrrolo[1,2-a]azepine}-5,5'(4H,6'H)-dione (2R,3'S,8'R,9a'S)-3'-hydroxymethyl-5,5'-dioxo-8'-methoxy-4-methylenehexahydro-3H-spiro{furan-2,9'-pyrrolo[1,2-a]azepin}-(4H,6'H)-carbaldehyde (2R,3'S,8'R,9a'S,2''R)-8'-methoxy-4-methylene-3'-[(2S)-4-methylene-5-oxotetrahydrofuran-2-yl]hexahydro-3H-spiro{furan-2,9'-pyrrolo[1,2-a]azepine}-5,5'(4H,6'H)-dione (2R,3'S,8'R,9a'S)-3'-hydroxymethyl-8'-methoxy-4-methylenehexahydro-3H-spiro{furan-2,9'-pyrrolo[1,2-a]azepin}-5,5'(4H,6'H)-dione protostemonine (3S,9R,10R,11S,15R)-3-[(2S,4S)-4-methyl-5-oxooxolan-2-yl]-10-prop-2-enyl-12-oxa-4-azatetracyclo[7.6.1.04,16.011,15]hexadec-6-en-13-one Tuberostemonin (1R,4S,10R,11R,12R,15S,16S)-11-ethyl-15-hydroxy-15-methyl-4-[(2S,4S)-4-methyl-5-oxooxolan-2-yl]-13-oxa-5-azatetracyclo[8.6.0.01,5.012,16]hexadecan-14-one (1R,3S,9R,10R,11S,14S,15S,16R)-3-[(2S)-4,4-dimethyl-5-oxooxolan-2-yl]-14-methyl-10-prop-2-enyl-12-oxa-4-azatetracyclo[7.6.1.04,16.011,15]hexadecan-13-one (3S,9R,10R,11S,14S,15S,16R)-10-ethyl-14-methyl-3-[(2S,4R)-4-methyl-5-oxooxolan-2-yl]-12-oxa-4-azatetracyclo[7.6.1.04,16.011,15]hexadecan-13-one (1S,2R,3S)-3-methyl-11-[(2S)-4-methyl-5-oxooxolan-2-yl]-5-oxa-10-azatricyclo[8.3.0.02,6]tridecan-4-one (9R,10R,11S,14S,15S,16R)-10-ethyl-14-methyl-12-oxa-4-azatetracyclo[7.6.1.04,16.011,15]hexadecan-13-one (10S,11S,14R,15R)-10-ethyl-14-methyl-3-[(2S,4S)-4-methyl-5-oxooxolan-2-yl]-12-oxa-4-azatetracyclo[7.6.1.04,16.011,15]hexadeca-1(16),2-dien-13-one